Constipation • Intestinal transit • Leaky gut • Inhibition of E. coli• Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
- Lactobacillus plantarum – LP01 (LMG P-21021)
Lactobacillus plantarum – LP01 (LMG P-21021)
Overview
Scientific reference(s)
Del Piano M. et al. The use of probiotics in the treatment of constipation in the elderly. CIBUS, 2005; 1(1):23-30.
Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012; 46 Suppl:S29-32.
Del Piano M. et al. In Vitro Sensitivity of Probiotics to Human Pancreatic Juice. J Clin Gastroenterol. Vol 42, Suppl. 3, Part 2, Sept. 2008.
Rossi M. et al. Fermentation of fructooligosaccharides and inulin by Bifidobacteria: a comparative study of pure and fecal cultures (BA02). Applied and Environmental Microbiology, 2005;71(10):6150-6158.
Further internal data on anti-inflammatory activity and intestinal barrier are available upon request
Internal in vitro data available upon request on above-mentioned functions and strain
Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains (LP01, LP02, LR04, LR06, LPS01, LDD01, BR03, B632). J Clin Gastroenterol. 2012; 46 Suppl:S29-32.
+ Internal data on anti-inflammatory and anti-oxidant properties available upon request for some of these strains
Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.
+ Internal data on anti-inflammatory and anti-oxidant properties available upon request on certain strains
Clinical studies on-going on LP01+LPC09+Bb1 and other actives in prostate health
Luca Magistrelli et al. Probiotics May Have Beneficial Effects in Parkinson’s Disease: In vitro Evidence. Front. Immunol., 07 May 2019
Additional info
Therapeutical area(s)
Gastrointestinal tract · Gut brain Axis · Healthy ageing · Urogenital system
Functionality
Antioxidant · Antipathogenic activity · Constipation · Cystitis · Kidney stones · Parkinson's disease
Age/Gender
Adults · Elderly
